CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (919) 636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,310,718
- in 4 filings, $1.2M under 10b5-1 plans
Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-16 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award · Restricted Share Unit (right to receive value of a share) | +50,000 | 778,958 | ||
| 2024-05-01 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,431 | $9.11 | $22K | 187,471 |
| 2024-04-30 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,042 | 105,313 | ||
| 2024-04-30 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Grant or award 10b5-1 | +2,431 | 189,902 | ||
| 2024-04-22 | Haigh Adrian CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +22,223 | $2.31 | $51K | 22,223 |
| 2024-04-22 | Haigh Adrian CHIEF OPERATING OFFICER | Sale 10b5-1 | −22,223 | $9.32 | $207K | 0 |
| 2024-04-22 | Haigh Adrian CHIEF OPERATING OFFICER | Option exercise · Option 10b5-1 | −22,223 | $2.31 | $51K | 360,246 |
| 2024-04-19 | Haigh Adrian CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +22,222 | $2.31 | $51K | 22,222 |
| 2024-04-19 | Haigh Adrian CHIEF OPERATING OFFICER | Sale 10b5-1 | −22,222 | $9.34 | $207K | 0 |
| 2024-04-19 | Haigh Adrian CHIEF OPERATING OFFICER | Option exercise · Option 10b5-1 | −22,222 | $2.31 | $51K | 382,469 |
| 2024-04-18 | Haigh Adrian CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +22,222 | $2.31 | $51K | 44,444 |
| 2024-04-18 | Haigh Adrian CHIEF OPERATING OFFICER | Sale 10b5-1 | +22,222 | $2.31 | $51K | 44,444 |
| 2024-04-18 | Haigh Adrian CHIEF OPERATING OFFICER | Sale 10b5-1 | −22,222 | $9.62 | $214K | 0 |
| 2024-04-18 | Haigh Adrian CHIEF OPERATING OFFICER | Option exercise · Common Shares 10b5-1 | −22,222 | $2.31 | $51K | 426,913 |
| 2024-04-17 | Haigh Adrian CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +22,222 | $2.31 | $51K | 22,222 |
| 2024-04-17 | Haigh Adrian CHIEF OPERATING OFFICER | Sale 10b5-1 | +22,222 | $2.31 | $51K | 22,222 |
| 2024-04-17 | Haigh Adrian CHIEF OPERATING OFFICER | Sale 10b5-1 | −22,222 | $9.91 | $220K | 22,222 |
| 2024-04-17 | Haigh Adrian CHIEF OPERATING OFFICER | Option exercise · Common Shares 10b5-1 | −22,222 | $2.31 | $51K | 449,135 |
| 2024-04-16 | Haigh Adrian CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +22,222 | $2.31 | $51K | 44,444 |
| 2024-04-16 | Haigh Adrian CHIEF OPERATING OFFICER | Sale 10b5-1 | +22,222 | $2.31 | $51K | 44,444 |
Page 14 of 17 · 340 trades